NWBO even identified the clinical PFS from the pseudo-progression. It is an endpoint in the NWBO "new" protocol and SAP == but the clinicians and NWBO are afraid to report it as it may once again reinforce the PFS failure. The naive OS treatment arm was statistically manipulated, so we don't really know the real results -- just NWBO manipulated endpoint - read the SAP filed with the JAMA Oncology manuscript.
Let's see if Dr. Laiu's boast of 50% survival after 100 months is REAL -- way out of line with any prior clinical evidence for either DCVax-L or Keytruda.
Market Data 
Markets 
AI
